Kiwi Wealth Investments Limited Partnership United Therapeutics Corp Transaction History

Kiwi Wealth Investments Limited Partnership

$126 Million
Q4 2023

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$174.81 - $241.14 $2.56 Million - $3.53 Million	14,626 New	14,626 $3.45 Million
Q1 2021 May 18, 2021	SELL	$153.94 - $174.85 $298,951 - $339,558	-1,942 Closed	0 $0
Q4 2020 Feb 17, 2021	SELL	$101.87 - $151.79 $1.73 Million - $2.58 Million	-17,027 Reduced 89.76%	1,942 $295,000
Q2 2020 Aug 14, 2020	BUY	$92.74 - $125.82 $1.76 Million - $2.39 Million	18,969 New	18,969 $2.3 Million

Others Institutions Holding UTHR

# of Institutions

672

Shares Held

42.4M

Call Options Held

194K

Put Options Held

295K

Black Rock Inc. New York, NY

5.47M
Shares

$1.98 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

4.41M
Shares

$1.59 Billion
0.03% of portfolio
Wellington Management Group LLP Boston, MA

3.17M
Shares

$1.15 Billion
0.2% of portfolio
Avoro Capital Advisors LLC New York, NY

2.86M
Shares

$1.03 Billion
15.42% of portfolio
State Street Corp Boston, MA

2.24M
Shares

$809 Million
0.03% of portfolio

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kiwi Wealth Investments Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Kiwi Wealth Investments Limited Partnership with notifications on news.

Account